In this week’s news: Dr. Jay Levy looks looks at elite controllers, a primer on mathematical modeling and HIV, and the FDA’s approval of Truvada as the first HIV prevention pill is the hot topic of the week
Latest research highlights: New microbicide delivery system, EAT-2 is a powerful gene-based adjuvant, infection with a harmless virus improves HIV prognosis, escape from bNabs, and immunization of newborns
In this week’s news: FDA approval of the do-it-yourself HIV test captured the news over the past seven days with a wide variety of opinions on both sides. While most people agree it is good news, a number of issues have been raised and the actual usefulness of the test in real world remains to be proven. Below...
In this week’s news: a NFID conference report, an adjuvant for the next-generation HIV vaccine candidate, zinc fingers used to destroy CCR5, cell-to-cell transmission during HAART challenged with new data, arguments on Green open access
In this week’s news: Envelope-only vaccine protects in monkeys, capsid is a potential new therapeutic target, combination drugs work better in preventing MTCT, open access advocates are not happy with the UK report recommending more open access
